Drugs that contain Alendronate Sodium

1. List of Binosto drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7964212 ASCEND THERAPS US Effervescent compositions comprising phosphonates and methods related thereto
Mar, 2023

(2 months ago)

US7488496 ASCEND THERAPS US Effervescent compositions comprising bisphosphonates and methods related thereto
Aug, 2023

(2 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9592195 ASCEND THERAPS US Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
Dec, 2031

(8 years from now)

Do you want to check out BINOSTO patents from before 2022?

Market Authorisation Date: 12 March, 2012

Treatment: NA

Dosage: TABLET, EFFERVESCENT;ORAL

More Information on Dosage

BINOSTO family patents

10

United States

3

Australia

3

Spain

3

Korea, Republic of

3

European Union

2

Canada

2

Denmark

1

Brazil

1

China

1

South Africa

1

Israel

1

Portugal

1

Russia

1

Poland

1

Malaysia

1

Turkey

1

Austria

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic